- Home
- VERX vs PCVX Comparison
VERX vs PCVX Comparison
Compare VERX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERX
- PCVX
- Stock Information
- Founded
- VERX 1978
- PCVX 2013
- Country
- VERX United States
- PCVX United States
- Employees
- VERX N/A
- PCVX N/A
- Industry
- VERX Computer Software: Prepackaged Software
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- VERX Technology
- PCVX Health Care
- Exchange
- VERX Nasdaq
- PCVX Nasdaq
- Market Cap
- VERX 3.9B
- PCVX 4.0B
- IPO Year
- VERX 2020
- PCVX 2020
- Fundamental
- Price
- VERX $24.86
- PCVX $40.80
- Analyst Decision
- VERX Buy
- PCVX Strong Buy
- Analyst Count
- VERX 14
- PCVX 8
- Target Price
- VERX $41.85
- PCVX $114.17
- AVG Volume (30 Days)
- VERX 1.5M
- PCVX 2.0M
- Earning Date
- VERX 11-03-2025
- PCVX 11-04-2025
- Dividend Yield
- VERX N/A
- PCVX N/A
- EPS Growth
- VERX N/A
- PCVX N/A
- EPS
- VERX N/A
- PCVX N/A
- Revenue
- VERX $710,512,000.00
- PCVX N/A
- Revenue This Year
- VERX $15.07
- PCVX N/A
- Revenue Next Year
- VERX $13.09
- PCVX N/A
- P/E Ratio
- VERX N/A
- PCVX N/A
- Revenue Growth
- VERX 15.00
- PCVX N/A
- 52 Week Low
- VERX $23.13
- PCVX $27.66
- 52 Week High
- VERX $60.71
- PCVX $118.62
- Technical
- Relative Strength Index (RSI)
- VERX 47.83
- PCVX 71.81
- Support Level
- VERX $24.30
- PCVX $31.89
- Resistance Level
- VERX $25.47
- PCVX $33.93
- Average True Range (ATR)
- VERX 0.86
- PCVX 1.94
- MACD
- VERX 0.17
- PCVX 1.05
- Stochastic Oscillator
- VERX 37.78
- PCVX 80.31
About VERX Vertex Inc.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.